Ehrlichia canis (IFA) - Travel Testing
The Ehrlichia canis IFA test is used to detect antibodies against Ehrlichia canis, the bacterium responsible for canine monocytic ehrlichiosis, through the indirect fluorescent antibody (IFA).The detection of antibodies to E. canis indicates exposure or an active infection, helping to confirm the presence of the disease and implement appropriate treatment. The IFA method is highly sensitive and specific, making it the preferred test for E. canis antibody detection, particularly in areas where tick-borne diseases are common.
Additionally, this test plays a critical role in pet travel compliance, as some countries require proof of a negative result for Ehrlichia canis as part of their import regulations.
2 ml Serum
Collect an adequate amount of blood in a plain red-top tube or serum separator tube (yellow-top tube). Allow it to clot at room temperature for 30 to 60 minutes before separation.
Centrifuge to separate the serum. Transfer the clear serum into a new, leak-proof plain red-top tube and label it as "serum."
Excessively hemolyzed samples are not suitable for this test.
Unspun samples will not be accepted.
Refrigerate sample at 4oC until shipment.
Label each sample with the animal’s name and a unique identifier, using a permanent marker or a secure adhesive label
Ensure the submittal form is completed with the animal’s information and relevant medical history.
Harrus, S., & Waner, T. "Ehrlichiosis in Dogs: Diagnostic Approaches and Treatment." Journal of Veterinary Internal Medicine, 2021.
Breitschwerdt, E.B., et al. "Advances in Tick-Borne Disease Testing in Veterinary Medicine." Veterinary Clinics of North America: Small Animal Practice, 2022.
Gaunt, S.D., & Beall, M.J. "Evaluation of IFA Testing for Ehrlichia canis Detection in Canines." Journal of Veterinary Diagnostic Investigation, 2023.